PROVECTUS BIOPHARMACEUTICALS, INC. Annual Net Cash Provided by (Used in) Financing Activities in USD from 2010 to 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.
Summary
Provectus Biopharmaceuticals, Inc. quarterly/annual Net Cash Provided by (Used in) Financing Activities history and growth rate from 2010 to 2023.
  • Provectus Biopharmaceuticals, Inc. Net Cash Provided by (Used in) Financing Activities for the quarter ending March 31, 2024 was $781K, a 51.5% increase year-over-year.
  • Provectus Biopharmaceuticals, Inc. annual Net Cash Provided by (Used in) Financing Activities for 2023 was $2.19M, a 60.2% increase from 2022.
  • Provectus Biopharmaceuticals, Inc. annual Net Cash Provided by (Used in) Financing Activities for 2022 was $1.37M, a 66% decline from 2021.
  • Provectus Biopharmaceuticals, Inc. annual Net Cash Provided by (Used in) Financing Activities for 2021 was $4.02M, a 11.8% increase from 2020.
Net Cash Provided by (Used in) Financing Activities, Annual (USD)
Net Cash Provided by (Used in) Financing Activities, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $2.19M +$824K +60.2% Jan 1, 2023 Dec 31, 2023 10-K 2024-03-28
2022 $1.37M -$2.66M -66% Jan 1, 2022 Dec 31, 2022 10-K 2024-03-28
2021 $4.02M +$424K +11.8% Jan 1, 2021 Dec 31, 2021 10-K 2023-03-30
2020 $3.6M -$3.15M -46.7% Jan 1, 2020 Dec 31, 2020 10-K 2022-03-29
2019 $6.75M +$1.6M +31.1% Jan 1, 2019 Dec 31, 2019 10-K 2021-03-02
2018 $5.15M -$4.17M -44.7% Jan 1, 2018 Dec 31, 2018 10-K 2020-03-05
2017 $9.32M Jan 1, 2017 Dec 31, 2017 10-K 2019-03-07
2013 $24.4M +$19.6M +409% Jan 1, 2013 Dec 31, 2013 10-K 2014-03-13
2012 $4.79M -$12M -71.5% Jan 1, 2012 Dec 31, 2012 10-K 2014-03-13
2011 $16.8M -$1.75M -9.44% Jan 1, 2011 Dec 31, 2011 10-K 2014-03-13
2010 $18.6M Jan 1, 2010 Dec 31, 2010 10-K 2013-03-14
* An asterisk sign (*) next to the value indicates that the value is likely invalid.